OppenheimerFunds’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-22,566
| Closed | -$439K | – | 1852 |
|
|
2018
Q1 | $439K | Sell |
22,566
-6,914
| -23% | -$135K | ﹤0.01% | 1457 |
|
|
2017
Q4 | $491K | Buy |
29,480
+3,977
| +16% | +$66.2K | ﹤0.01% | 1521 |
|
|
2017
Q3 | $517K | Sell |
25,503
-17,427
| -41% | -$353K | ﹤0.01% | 1504 |
|
|
2017
Q2 | $691K | Sell |
42,930
-22,593
| -34% | -$364K | ﹤0.01% | 1346 |
|
|
2017
Q1 | $828K | Buy |
65,523
+22,521
| +52% | +$285K | ﹤0.01% | 1252 |
|
|
2016
Q4 | $570K | Sell |
43,002
-214,513
| -83% | -$2.84M | ﹤0.01% | 1314 |
|
|
2016
Q3 | $6.1M | Buy |
257,515
+10,141
| +4% | +$240K | 0.01% | 799 |
|
|
2016
Q2 | $7.13M | Buy |
247,374
+6,377
| +3% | +$184K | 0.01% | 765 |
|
|
2016
Q1 | $7.72M | Buy |
240,997
+232,275
| +2,663% | +$7.44M | 0.01% | 758 |
|
|
2015
Q4 | $373K | Buy |
+8,722
| New | +$373K | ﹤0.01% | 1419 |
|